Join
Live feed
·
PRReleasevia Quantisnow
Social Capital Suvretta Holdings Corp. III logo

Revolutionary Chronic Kidney Disease Therapeutics Company ProKidney to List on the Nasdaq Following Business Combination with Social Capital Suvretta Holdings Corp. III

ByQuantisnow·Wall Street's wire, on your screen.
DNAC· Social Capital Suvretta Holdings Corp. III

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track DNAC (Social Capital Suvretta Holdings Corp. III) and more on Quantisnow.